TerezaMartinuMD
Pulmonology • Lumberton, NCCritical Care Medicine
Assistant Professor, Medicine, Duke University School of Medicine
Are you Dr. Martinu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 W 27th St
Lumberton, NC 28358Phone+1 910-671-5000Fax+1 919-684-5266- Is this information wrong?
Summary
- Dr. Tereza Martinu, MD is a pulmonologist in Lumberton, North Carolina. She is currently licensed to practice medicine in North Carolina and Illinois. She is an Assistant Professor at Duke University School of Medicine.
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008- Duke University HospitalResidency, Internal Medicine, 2002 - 2005
McGill University Faculty of MedicineClass of 2002
Certifications & Licensure
NC State Medical License 2005 - 2024
IL State Medical License 2019 - 2023
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 11 citationsEngineered mesenchymal stromal cell therapy during human lung ex vivo lung perfusion is compromised by acidic lung microenvironment.A.I. Nykanen, A. Mariscal, A. Duong, Catalina Estrada, Aadil Ali, Olivia Hough, A.T. Sage, B.T. Chao, Manyin Chen, H. Gokhale, Hongchao Shan, Xiao-Hui Bai, G. Zehong, ...> ;Molecular Therapy. Methods & Clinical Development. 2021 Dec 10
- 4 citationsSignificance of phenotype change after Chronic Lung Allograft Dysfunction onsetEyal Fuchs, Liran Levy, Ella Huszti, B. Renaud-Picard, Gregory Berra, M. Kawashima, A. Takahagi, R. Ghany, Jan Havlin, Micheal McInnis, Shaf Keshavjee, Lianne G. Singe...> ;Transplant International. 2021 Nov 8
- 1 citationsRecipient bone marrow-derived IL-17 receptor A-positive cells drive allograft fibrosis in a mouse intrapulmonary tracheal transplantation modelTatsuaki Watanabe, Stephen C. Juvet, K. Boonstra, Z. Guan, Betty Joe, Grace Teskey, Shaf Keshavjee, Tereza Martinu> ;Transplant Immunology. 2021 Dec 1
- Join now to see all
Press Mentions
IL‐6 Receptor Blockade for Allograft Dysfunction After Lung Transplantation in a Patient with COPA SyndromeJanuary 28th, 2021
ISHLT Elects New Board MembersJanuary 7th, 2021
Ontario Boy Almost Needed Double-Lung Transplant After Vaping: DoctorsNovember 21st, 2019- Join now to see all
Grant Support
- Role Of CXC Chemokines At The Innate-Adaptive Interface Of Alloimmune Lung InjuryNational Heart, Lung, And Blood Institute2007
